ArticleBMC medical research methodology2025
Two-stage sampling for better survival model performance.
Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundWith the emergence of high-dimensional censored survival data in health and medicine, the use of survival models for risk prediction is increasing. To date, practical techniques exist for splitting data for model training and performance evaluation. While different sampling methods have been compared for their performances, the effect of data splitting ratio and survival specific characteristics have not yet been examined for high dimensional censored survival data.
methodsWe first conduct an empirical study of using the simple random sampling technique and stratified sampling technique on real high-dimensional gene expression datasets Lasso Cox model performance. For the simple random sampling technique, various data splitting ratios are investigated. For the stratified sampling, different survival specific variables are investigated. We consider C-index and Brier Score as evaluation metrics. We further develop and validate a two-stage purposive sampling approach motivated by our empirical study findings.
resultsOur findings reveal that survival specific characteristics contribute to model performance across training, testing and validation data. The proposed two-stage purposive sampling approach performs well in mitigating excessive diversity within the training data for both simulation study and real data analysis, leading to better survival model performances.
conclusionsWe recommend careful consideration of key factors in different sampling techniques when developing and validating survival models. Using methods such as the proposed method to mitigate excessive diversity provides a solution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.